FIGURE 5.

The U2OS and SAOS‐2 cells shrank, decreased round and smooth when challenged with TMPyP4 or cisplatin in the inflammatory microenvironment, while the cisplatin or cisplatin combined with TNF‐α or LPS group became elongated. (A) and (B) Cells were treated with TMPyP4 or cisplatin in the presence or absence of TNF‐α (10 ng/mL) or LPS (1 μg/mL) for the indicated times, and then, phase contrast images were captured. Magnification: 100×